Highlights for Monday, June 6

2016-06-06

Rhythm vs rate control in atrial fibrillation after surgery

Gillinov AM, Bagiella E, Moskowitz AJ, et al; CTSN. Rate Control versus Rhythm Control for Atrial Fibrillation after Cardiac Surgery. N Engl J Med. 2016 May 19;374(20):1911-21. doi: 10.1056/NEJMoa1602002. Epub 2016 Apr 4. PubMed PMID: 27043047.
Calkins H. Is Less More for the Treatment of Atrial Fibrillation after Cardiac Surgery? N Engl J Med. 2016 May 19;374(20):1977-8. doi: 10.1056/NEJMe1604311. PubMed PMID: 27192676.

Among patients who developed atrial fibrillation following coronary artery bypass grafting (CABG) surgery, the use of rate control was not inferior to rhythm control (amiodarone followed by cardioversion within 24 to 48 hours), with 94% of patients in the rate-control group versus 98% in the rhythm-control group with a stable rhythm without atrial fibrillation for at least 30 days at day 60. This clinical scenario occurs in about 30% of all patients after CABG surgery.

Authors interpret their results as showing no advantage of either strategy.

Treatment, no treatment, or placebo for unprovoked seizures

Leone MA, Giussani G, Nolan SJ, Marson AG, Beghi E. Immediate antiepileptic drug treatment, versus placebo, deferred, or no treatment for first unprovoked seizure. Cochrane Database Syst Rev. 2016 May 6;5:CD007144. doi: 10.1002/14651858.CD007144.pub2. Review. PubMed PMID: 27150433.

Following first unprovoked seizures, immediate treatment (rather than no treatment, placebo, or deferred treatment) is associated with fewer recurrent seizures after 1 year (19% vs 39%) and 5 years (37% vs 47%) as well as a higher probability of events classified as adverse (30% vs 20% over a period of time ranging from months to several years).

These results will inform decisions of patients and clinicians facing this reasonably frequent management dilemma.

Intravenous magnesium in children with acute asthma

Griffiths B, Kew KM. Intravenous magnesium sulfate for treating children with acute asthma in the emergency department. Cochrane Database Syst Rev. 2016 Apr 29;4:CD011050. doi: 10.1002/14651858.CD011050.pub2. Review. PubMed PMID: 27126744.

Intravenous magnesium (25-75 mg/kg) used as an adjunct to steroids and bronchodilators has decreased the need for hospital admissions in children presenting with acute asthma exacerbation to the emergency department.

These results add to the similar evidence in adults, although authors point out the relative heterogeneity of findings between studies and the overall small number of involved children (<200).

See also

We would love to hear from you

Comments, mistakes, suggestions?

We use cookies to ensure you get the best browsing experience on our website. Refer to our Cookies Information and Privacy Policy for more details.